John Petry's Net Worth
$53.8 Million
Who is John Petry?
John Petry has an estimated net worth of $53.8 Million. This is based on reported shares across multiple companies, which include COMPX INTERNATIONAL INC, Garrett Motion Inc., Provention Bio, Inc., and SAB Biotherapeutics, Inc..
SEC CIK
John Petry's CIK is 0001618702
Past Insider Trading and Trends
2023 was John Petry's most active year for acquiring shares with 9 total transactions. John Petry's most active month to acquire stocks was the month of October. 2023 was John Petry's most active year for disposing of shares, totalling 11 transactions. John Petry's most active month to dispose stocks was the month of March. 2023 saw John Petry paying a total of $124,461,138.00 for 13,579,011 shares, this is the most they've acquired in one year. In 2023 John Petry cashed out on 33,343,458 shares for a total of $112,743,151.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMPX INTERNATIONAL INC (CIX) Snapshot price: $24.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Garrett Motion Inc. (GTX) Snapshot price: $8.415
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.63% | -10.00M |
$9.00 | -$90,000,000.00 | 15.24M |
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -6.91M |
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Provention Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.57M |
—
|
—
|
0
|
Apr 27
| |||
Form 4
| -100.00% | -426.93K |
—
|
—
|
0
|
Apr 20 - Apr 21
| |||
Form 4
| +75.33% | 6.69M |
$15.16 | -$13.68 | 15.57M |
Apr 14
| |||
Form 4
| -25.70% | -3.22M |
—
|
—
| 9.31M |
Mar 31 - Apr 4
| |||
Form 4
| -20.16% | -3.00M |
$9.40 | -$28,200,000.00 | 11.88M |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SAB Biotherapeutics, Inc. (SABS) Snapshot price: $5.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.58M |
—
|
—
| 4.58M |
Nov 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10 - Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||